Re: Question for posters
|
6
|
Resverlogix Corp.
|
Dec 10, 2021 04:14PM
|
Compensation
|
6
|
Resverlogix Corp.
|
May 21, 2022 01:13PM
|
Re: Watch it before it gets moved to "Off Topic Forum" by the thought police here.
|
6
|
Zenith Epigenetics
|
Apr 04, 2020 10:58AM
|
AGM attendance
|
6
|
Resverlogix Corp.
|
May 21, 2022 01:38PM
|
Re: Thoughts on ZCC
|
6
|
Zenith Epigenetics
|
Sep 06, 2021 01:07PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
6
|
Zenith Epigenetics
|
May 14, 2022 01:15PM
|
Re: RBC unregistered to registered account
|
6
|
Zenith Epigenetics
|
Apr 01, 2019 09:20PM
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
6
|
Resverlogix Corp.
|
Nov 01, 2021 09:45AM
|
Re: Question for the board!
|
6
|
Zenith Epigenetics
|
Jan 22, 2019 04:23PM
|
Re: Breaking down the Webcast
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 01:54PM
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 11:45AM
|
Re: Warning: Long - Thoughts on Management
|
6
|
Resverlogix Corp.
|
Mar 25, 2021 06:29PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
6
|
Resverlogix Corp.
|
May 09, 2022 01:10PM
|
Promissory Note
|
6
|
Zenith Epigenetics
|
Mar 09, 2021 04:20PM
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 10:52AM
|
Re: Name Confusion
|
6
|
Zenith Epigenetics
|
Aug 12, 2020 12:16PM
|
Re: Don's April 14th Interview on the Drive
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 01:16PM
|
Re: ZHCLF trades on the OTC
|
6
|
Zenith Epigenetics
|
Jan 21, 2021 03:03PM
|
Re: A Special Meeting of Shareholders?
|
6
|
Resverlogix Corp.
|
May 30, 2024 03:55PM
|
clinicaltrials.gov
|
6
|
Resverlogix Corp.
|
May 15, 2021 03:04PM
|